We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
GWS
301
Glassman Wealth Services
Virginia
– -$11.1K -35 Closed
AF
302
Allworth Financial
California
– -$8.23K -26 Closed
Northwestern Mutual Wealth Management
303
Northwestern Mutual Wealth Management
Wisconsin
– -$8.23K -26 Closed
CWC
304
Carolinas Wealth Consulting
North Carolina
– -$6.01K -19 Closed
BTI
305
Blue Trust Inc
Georgia
– -$2K -12 Closed
PS
306
Principal Securities
Iowa
– -$3.8K -12 Closed
WTA
307
Washington Trust Advisors
Massachusetts
– -$3.48K -11 Closed
BL
308
BFSG LLC
California
– -$3.17K -10 Closed
MPWT
309
MassMutual Private Wealth & Trust
Connecticut
– -$2.85K -9 Closed
CAL
310
Capital Advisors Ltd
Ohio
– -$3K -8 Closed
BWL
311
Bogart Wealth LLC
Virginia
– -$2.22K -7 Closed
PWMG
312
Prestige Wealth Management Group
New Jersey
– -$1.9K -6 Closed
BIA
313
Bell Investment Advisors
California
– -$1.58K -5 Closed
FFA
314
Farther Finance Advisors
California
– -$1.58K -5 Closed
JWM
315
Janiczek Wealth Management
Colorado
– -$1.58K -5 Closed
SWM
316
Spire Wealth Management
Virginia
– -$1.58K -5 Closed
BAM
317
Bellevue Asset Management
Washington
– -$1.27K -4 Closed
PPC
318
Park Place Capital
Alabama
– -$1.27K -4 Closed
WT
319
Whittier Trust
California
– -$1.27K -4 Closed
PWMG
320
Private Wealth Management Group
New Jersey
– -$950 -3 Closed
BFEC
321
Benjamin F. Edwards & Company
Missouri
– -$1K -2 Closed
PFBT
322
Parkside Financial Bank & Trust
Missouri
– -$634 -2 Closed
BF
323
BOK Financial
Oklahoma
– -$316 -1 Closed
CFGS
324
Concourse Financial Group Securities
Alabama
– -$316 -1 Closed
IFAM
325
Institutional & Family Asset Management
Colorado
– -$317 -1 Closed
10 11 12
13
14

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.